miDiagnostics NV
USPTO PatentsView assignee record - 15 granted patents across 7 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01L (Chemical OR Physical Laboratory Apparatus FOR General USE).
The verdict
According to USPTO PatentsView, midiagnostics ranks #18,901 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 7 technology areas.
- #18,901
- of 49,997 US assignees by volume
- Top 25%
- by Innovation Score (44.7/100)
- 12.4
- avg claims per patent
- +550%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R18901 · Foreign Corporation #18,901 · 15 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 15 grants
- MID-PACK #18,901/49,997
- PHOTO-FINISH ams Sensors Germany
- CPC-NARROW B01L · 7 areas
- INNOV-PAR 44.7/100
- CLAIMS-RICH 12.4 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +550% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: ams Sensors Germany GmbH (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How midiagnostics’s 44.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around midiagnostics
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Amano Enzyme · near
Amano Enzyme · near
45 score
- China International… · near
China International… · near
45 score
- Enlighted · near
Enlighted · near
45 score
- G&H Diversified… · near
G&H Diversified… · near
45 score
- miDiagnostics · this assignee
miDiagnostics · this assignee
45 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows midiagnostics's Innovation Score is 44.7/100 (top 25% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for midiagnostics?
Each dot is one of midiagnostics’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). midiagnostics’s own 12.4 claims/patent is at or below the 18.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where midiagnostics's grants concentrate
miDiagnostics NV is a focused PatentsView assignee: 7 CPC subclasses with 46.7% of grants classified under B01L (Chemical OR Physical Laboratory Apparatus FOR General USE). Peak complete grant year is 2023 (6 grants) versus a trough of 1 in 2024. By volume, midiagnostics sits between ams Sensors Germany GmbH and 4D Pharma PLC.
midiagnostics's three-year grant acceleration
miDiagnostics NV shows 11 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at miDiagnostics's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- ams Sensors Germa…
ams Sensors Germany GmbH
15 patents
- epro
epro GmbH
15 patents
- ipek International
iPEK International GmbH
15 patents
- izotope
iZotope, Inc.
15 patents
- ncap Licensing
nCap Licensing, LLC
15 patents
- midiagnostics ◀
miDiagnostics NV
15 patents
- 1ahead
1ahead Technologies
14 patents
- 3play Media
3Play Media, Inc.
14 patents
- 4D Pharma
4D Pharma PLC
14 patents
What this shows miDiagnostics holds 15 patents at rank #19,389, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near miDiagnostics
By rank, the assignees closest to #19,389 in granted patent volume.
- ams Sensors Germany GmbH #19,385 · 15 patents
- epro GmbH #19,386 · 15 patents
- iPEK International GmbH #19,387 · 15 patents
- iZotope, Inc. #19,388 · 15 patents
- nCap Licensing, LLC #19,390 · 15 patents
- 1ahead Technologies #19,391 · 14 patents
- 3Play Media, Inc. #19,392 · 14 patents
- 4D Pharma PLC #19,393 · 14 patents
Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)
Other assignees with the most granted patents in miDiagnostics's primary technology class.
- The Regents of the University of California 239 in class
- Illumina, Inc. 232 in class
- Becton, Dickinson and Company 193 in class
- Bio-Rad Laboratories, Inc. 174 in class
- President and Fellows of Harvard College 165 in class
- Life Technologies Corporation 158 in class
- Roche Diagnostics Operations, Inc. 141 in class
- Siemens Healthcare Diagnostics Inc. 119 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for miDiagnostics, neither rank-band nor same-CPC leaders (those blocks stay above). In B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), miDiagnostics ranks #279 of 1,325 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (45 here).
midiagnostics's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
45 Top 25% higher than 75% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 2 | 13.3% |
| 2021 | 2 | 13.3% |
| 2022 | 4 | 26.7% |
| 2023 | 6 | 40.0% |
| 2024 | 1 | 6.7% |
Which technologies does miDiagnostics NV patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
miDiagnostics NV's patent record in context - here's where to go next.
- miDiagnostics NV's lead technology class is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), 46.7% of its portfolio - see every assignee active in that class. Explore B01L
- Ranked #18,901 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare miDiagnostics NV against ams Sensors Germany GmbH, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 44.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.